It's interesting that you call it *advice* as this may constitute a violation in many states. Do you have a series 7 to go with that *advice*? Think twice, "researcher" before you tell people how to invest. regulus is kicking VICL's buttocks, oh, and they use antisense, just like the cells in your body. Please explain with scientific facts why Regulus is outperforming VICL and why Fidelity just bought close to 500,000 shares of ISIS. But you know better?
Sentiment: Strong Buy